Historical performance in the Life Sciences category.
Source: Acquire.fyi, Jan 1, 2025 - Jul 13, 2026.
Largest mergers and acquisitions by disclosed deal value.
| Acquirer | Target | Type | Value | Headline |
|---|---|---|---|---|
| Blackstone and TPG | Hologic, Inc. | Acquisition | $18.3B | Blackstone and TPG to acquire Hologic, Inc. in $18,300.0M cash and contingent value right deal |
| Sun Pharmaceutical Industies | Organon & Co | Acquisition | $11.7B | Sun Pharmaceutical Industies to acquire Organon & Co in $11,698.4M deal |
| Gilead Sciences | Arcellx | Acquisition | $7.6B | Gilead Sciences acquires Arcellx in $7,589.0M deal |
| Novartis | Myricx Bio | Acquisition | $1.5B | Novartis Bets $1.5 Billion on Myricx ADC Payload Platform |
| Agilent Technologies Inc. | Biocare Medical | Acquisition | $950M | Agilent Technologies Inc. to acquire Biocare Medical in $950.0M cash deal |
| Enpro Inc. | AlpHa Measurement Solutions and Overlook Industries | Acquisition | $280M | Enpro Inc. acquires AlpHa Measurement Solutions and Overlook Industries in $280.0M cash deal |
| Transcat, Inc. | Essco Calibration Laboratory | Acquisition | $84M | Transcat, Inc. acquires Essco Calibration Laboratory in $84.0M cash deal |
| Tempus AI, Inc. | Paige | Acquisition | $81.3M | Tempus AI, Inc. acquires Paige in $81.3M predominantly in tempus common stock deal |
| Transcat, Inc. | SCM Metrology and Laboratories S.A. | Acquisition | $13M | Transcat, Inc. acquires SCM Metrology and Laboratories S.A. in $13.0M cash deal |
| Veristat | Certara’s Regulatory and Medical Writing business | Acquisition | Undisclosed | Veristat to acquire Certara’s Regulatory and Medical Writing business |
Page 1 of latest articles and deal coverage.
The deal gives Novartis a differentiated antibody drug conjugate engine as large pharma races to secure better-tolerated oncology assets before clinical validation drives prices higher.